Pharmafile Logo
Pharmafocus logo
Advanced Search
lance2

A day in the life: Lance Hill, CEO at Within3

May 17, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing A day in the life, Interview, Within3, feature

Could you give a short history of how you came to be in your current role? I’ve spent my entire …

Feature

Insider Interview: Paving paths in prostate cancer

May 16, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Interview, Janssen, feature, pharma, prostate cancer

Joaquin Casariego Garcia Luben, Medical Affairs Director Europe, Middle East & Africa, Prostate Cancer for Johnson & Johnson (pictured) discusses …

Feature

Pfizer’s abrocitinib smashes primary and secondary endpoints at Phase 3 in atopic dermatitis

May 16, 2019
Research and Development Pfizer, abrocitinib, atopic dermatitis, pharma

Pfizer has lifted the curtain on new Phase 3 data for its Janus kinase 1 (JAK1) inhibitor abrocitinib, revealing that …

News
5204602349_c87b204860_z

ImmunoGen shares plummet by 32% after FDA recommends new Phase 3 trial

May 16, 2019
Business Services, Research and Development Cancer, Immunogen, Shares, ovarian cancer, pharma, stocks

Shares in ImmunoGen fell 32% in premarket trading after the firm said the FDA had recommended a new Phase 3 …

News

FDA greenlights Roche and AbbVie’s Venclexta for chronic lymphocytic leukaemia

May 16, 2019
Sales and Marketing AbbVie, Cancer, FDA, Roche, Venclexta, leukaemia, pharma

Venclexta (venetoclax), the oral B-cell lymphoma-2 (BCL-2) inhibitor co-developed by AbbVie and Roche, has been approved by the FDA in …

News
novartis_window

Novartis’ Kymriah to be covered by Japan’s national insurance system

May 16, 2019
Medical Communications, Sales and Marketing CAR T, CAR-T, Japan, Kymriah, Novartis, pharma

Japan’s national medical insurance system will pay for Novartis’ CAR-T therapy Kymriah following approval from the Central Social Insurance Medical …

News

J&J to invest €100 million into Limerick manufacturing facilities creating 100 new jobs

May 16, 2019
Manufacturing and Production Ireland, J&J, JJ, Limerick, medical technology, pharma

Healthcare conglomerate Johnson & Johnson has said it will be investing €100 million into the expansion of its Vision Care …

News

EUSA Pharma bolsters senior leadership team with two appointments

May 15, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eusa Pharma, appointment

Rare disease and oncology biopharma firm EUSA Pharma has revealed two new additions to its senior leadership team in two …

Appointment
123_dott_paolo_chiesi_550

Paola Chiesi awarded honorary doctorate by Karolinska Institutet

May 15, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Paolo Chiesi, Vice President of the Chiesi Group, has been made an Honorary Doctor at the Karolinska Institutet – a …

Appointment
index_ph001

Two Daiichi Sankyo drugs dealt a thumbs up and thumbs down by FDA advisory panel

May 15, 2019
Research and Development, Sales and Marketing Daiichi Sankyo, FDA, pexidartinib, pharma, quizartinib

Daiichi Sankyo was left with a bittersweet taste in its mouth after it saw one of its drugs recommended for …

News

Pfizer & Merck’s Inlyta combo becomes first FDA-approved anti-PD-L1 therapy for kidney cancer

May 15, 2019
Research and Development, Sales and Marketing FDA, Merck KGaA, Pfizer, inylta, pharma, renal cell carcinoma

The FDA has approved Bavencio (avelumab) in combination with Inlyta (axitinib) for the treatment of advanced renal cell carcinoma (RCC). …

News

NHS England agree to pay for Biogen’s $750,000 a year SMA treatment Spinraza

May 15, 2019
Research and Development Biogen, NHS England, Spinraza, UK, pharma, sma, spinal muscular atrophy

NHS England has agreed to pay an undisclosed price for Biogen’s spinal muscle atrophy (SMA) treatment Spinraza. England’s National Health …

News
gilead-sciences

Gilead struck anti-competitive deals to retain dominance in HIV market, lawsuit says

May 15, 2019
Research and Development AIDS, BMS, Gilead, HIV, Janssen, generic drugs

Gilead Sciences struck anti-competitive deals with Janssen and Britsol-Myers Squibb in an effort to retain dominance in the market for …

News
stormotion

Medical Affairs 2025 – Excellence in the era of precision medicine

May 15, 2019
Medical Communications, Research and Development pharma, veeva

Medical affairs is at the leading edge of a trend. As the life sciences industry shifts towards precision medicine, its …

News

Ex-GSK, Novartis exec named as Mundipharma’s Head of Access

May 14, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, appointment, pharma

Mundipharma has announced that Jerome Moreau has joined the company as its new Head of Market Access. Moreau has amassed …

Appointment
sleeping-baby-1540295803spt

Prophylactic antibiotic use could halve post-birth maternal infections, study indicates

May 14, 2019
Manufacturing and Production, Research and Development Antibiotics, University of Oxford, pharma

A study led by researchers at the University of Oxford has argued that the administration of preventative antibiotics to all …

News
ipos0_l

FDA expands indication for Eylea to cover all stages of diabetic retinopathy

May 14, 2019
Manufacturing and Production Bayer, Eylea, FDA, Regeneron, approval, pharma

The FDA has expanded the indication for Regeneron’s Eylea (aflibercept) to include all stages of diabetic retinopathy. Regeneron chief scientific …

News
mental-health-3332122_960_720

Mental health spending varies dramatically among regions in England, analysis shows

May 14, 2019
Manufacturing and Production England, NHS, UK, mental health, mind, spending

Spending on mental health varies dramatically between regions in England, according to analysis from mental health charity Mind. South Yorkshire …

News
merck-keytruda

MSD’s Keytruda recommended on NHS in Scotland for Stage 3 melanoma

May 14, 2019
Manufacturing and Production, Sales and Marketing Cancer, MSD, Scotland, Scottish Medicines Consortium, keytruda, melanoma, pharma

MSD has revealed that Keytruda (pembrolizumab) will be made available to NHS Scotland patients after the Scottish Medicines Consortium (SMC) …

News
chinese_flag_beijing_-_img_1104

Chinese pharmaceuticals will not be subject to tariffs, US Trade Representative says

May 14, 2019
Manufacturing and Production China, US, USTR, pharma, tariffs, trade

The Office of the United States Trade Representative (USTR) has said pharmaceuticals will not be subject to potential US tariffs …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026